These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 12003180

  • 1. An observational study on patients treated or not for acute HIV infection.
    Mussini C, Cozzi-Lepri A, Bedini A, Borghi V, Mongiardo N, Cossarizza A, Esposito R.
    J Biol Regul Homeost Agents; 2002; 16(1):79-82. PubMed ID: 12003180
    [Abstract] [Full Text] [Related]

  • 2. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M.
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [Abstract] [Full Text] [Related]

  • 3. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [Abstract] [Full Text] [Related]

  • 4. Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.
    Vogel M, Lichterfeld M, Kaufmann DE, Mui SK, Altfeld M, Voigt E, Ahlenstiel G, Kupfer B, Walker B, Spengler U, Rockstroh JK.
    Eur J Med Res; 2006 Jul 31; 11(7):273-8. PubMed ID: 16899420
    [Abstract] [Full Text] [Related]

  • 5. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F, Grasso M, Lodini S, Capiluppi B, Lazzarin A, Tambussi G.
    J Biol Regul Homeost Agents; 2002 Jul 31; 16(1):49-52. PubMed ID: 12003174
    [Abstract] [Full Text] [Related]

  • 6. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.
    AIDS; 2008 Aug 20; 22(13):1583-8. PubMed ID: 18670217
    [Abstract] [Full Text] [Related]

  • 8. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL.
    APMIS Suppl; 2003 Aug 20; (114):1-37. PubMed ID: 14626050
    [Abstract] [Full Text] [Related]

  • 9. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
    Achenbach CJ, Till M, Palella FJ, Knoll MD, Terp SM, Kalnins AU, Murphy RL.
    HIV Med; 2005 Jan 20; 6(1):7-12. PubMed ID: 15670246
    [Abstract] [Full Text] [Related]

  • 10. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S, QUEST Study Group.
    Clin Infect Dis; 2007 Aug 01; 45(3):381-90. PubMed ID: 17599319
    [Abstract] [Full Text] [Related]

  • 11. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec 01; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
    Fernández Guerrero ML, Rivas P, Molina M, Garcia R, De Górgolas M.
    Clin Infect Dis; 2005 Aug 01; 41(3):390-4. PubMed ID: 16007538
    [Abstract] [Full Text] [Related]

  • 13. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.
    HIV Med; 2006 Mar 01; 7(2):99-104. PubMed ID: 16420254
    [Abstract] [Full Text] [Related]

  • 14. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
    Llibre JM, Domingo P, del Pozo MA, Miralles C, Galindo MJ, Viciana I, Moreno S, Schapiro JM, Clotet B.
    J Antimicrob Chemother; 2008 Jan 01; 61(1):206-9. PubMed ID: 17999972
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327
    [Abstract] [Full Text] [Related]

  • 16. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.
    Henrard DR, Daar E, Farzadegan H, Clark SJ, Phillips J, Shaw GM, Busch MP.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul 01; 9(3):305-10. PubMed ID: 7788430
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B, García F, Gutierrez C, Martinez-Picado J, Aguilera A, Saumoy M, Vallejo A, Domingo P, Dalmau D, Ribas MA, Blanco JL, Pedreira J, Perez-Elias MJ, Leal M, de Mendoza C, Soriano V, Red de Investigación en SIDA.
    J Med Virol; 2005 Sep 01; 77(1):23-8. PubMed ID: 16032728
    [Abstract] [Full Text] [Related]

  • 20. Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?
    Madec Y, Boufassa F, Rouzioux C, Delfraissy JF, Meyer L, SEROCO Study Group.
    Clin Infect Dis; 2005 May 01; 40(9):1350-4. PubMed ID: 15825038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.